Liver methylation of NADH dehydrogenase 6 (MT-ND6) correlates with NAFLD severity, resulting in significantly lower expression of MT-ND6 mRNA in NASH than in patients with simple steatosis [54]. Here, MT-ND6 is linked to metabolic dysfunction-associated steatohepatitis.